JOHNSON DAVID LEE (Chief Operating Officer) received a stock award from VERA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/6/2026ACC: 0001733883-26-000002
Officer· Chief Operating Officer
Since Feb 2026
+60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
60K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
70.7%
2/4/2026
28.31K→48.31K
Total
Net shares
+20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/4/2026 | A · Award | +20K | — | — | 70.7% | 28.31K | 48.31K |
| Total | +20K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
40K shares
Shares
+40K
Strike price
42.74
Held after
40K
Exercisable
—
2/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock40K shares | 2/4/2026 | A · Award | +40K | 42.74 | — | 40K |